Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.
Press releases published on August 27, 2025
Parallels Launches Parallels Desktop 26 with Support for macOS Tahoe 26, Compatibility with Windows 11 25H2, and New IT Management Tools
GlobeNewswire
·
August 27, 2025
AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Parallels, a global leader in cross-platform virtualization solutions, today announced the launch of Parallels Desktop 26, featuring compatibility with the upcoming release of macOS Tahoe 26 and Windows 11 …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
August 27, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
GlobeNewswire
·
August 27, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 27 août 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
JointCommerce Expands Programmatic Capabilities to Help Retailers and Brands in Highly Regulated Verticals Reach Verified Consumers and Link Ads to Sales
GlobeNewswire
·
August 27, 2025
JointCommerce Logo LOS ANGELES, Aug. 27, 2025 (GLOBE NEWSWIRE) -- JointCommerce, a programmatic advertising technology and consumer data marketplace platform, today announced expanded capabilities that enable retailers and brands in highly regulated …
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
GlobeNewswire
·
August 27, 2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU residents …
Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 27, 2025
SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …